[Bufexamac-induced pigmented purpuric eruption].
We report on a case of a bufexamac-induced allergic contact dermatitis with hematogenous dissemination presenting with the clinical and histological picture of a pigmented purpuric eruption. To our knowledge this is the first report on a bufexamac-induced pigmented purpuric dermatosis. It represents a further example of the clinical variety of cutaneous side-effects caused by bufexamac.
Waltermann
K
K
Klinik für Dermatologie, Venerologie und Allergie, Universitätsklinikum Essen, Hufelandstrasse 55, 45122, Essen, Deutschland. katharina.waltermann@uk-essen.de
Marsch
W Ch
WCh
Kreft
B
B
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002019:Bufexamac / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis* / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control; D011693:Purpura / Q000139:chemically induced* / Q000175:diagnosis* / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002019:Bufexamac